TNYA

Tenaya Therapeutics (TNYA)

About Tenaya Therapeutics (TNYA)

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.

Details

Daily high

$0.71

Daily low

$0.63

Price at open

$0.70

52 Week High

$5.32

52 Week Low

$0.39

Market cap

106.3M

Dividend yield

0.00%

Volume

2.2M

Avg. volume

5.9M

P/E ratio

-.50

Tenaya Therapeutics News